Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Gast

Showing results (41-50 of 54) with videos related to

Pageof 6
Sort By:
Trends in Pharmacological Sciences|April 8, 2006
Clinical proteomics: searching for better tumour markers with SELDI-TOF mass spectrometryJudith Y M N Engwegen, Marie-Christine W Gast, Jan H M Schellens, et al.
Biofizika|November 1, 1989
[Phagocytic activity of granulocytes after UV-irradiation]T Walter, M Rytter, W Gast, et al.
BMC Bioinformatics|February 9, 2008
Comparison of normalisation methods for surface-enhanced laser desorption and ionisation (SELDI) time-of-flight (TOF) mass spectrometry dataWouter Meuleman, Judith Ymn Engwegen, Marie-Christine W Gast, et al.
BMC Bioinformatics|February 12, 2009
Analysis of mass spectrometry data using sub-spectraWouter Meuleman, Judith Y M N Engwegen, Marie-Christine W Gast, et al.
Cancer Biomarkers : Section a of Disease Markers|February 1, 2007
SELDI-TOF MS serum protein profiles in breast cancer: assessment of robustness and validityM C W Gast, J M G Bonfrer, E J van Dulken, et al.
BMC Medical Genomics|January 21, 2009
Validation of previously identified serum biomarkers for breast cancer with SELDI-TOF MS: a case control studyAnnemieke W J van Winden, Marie-Christine W Gast, Jos H Beijnen, et al.
Proteomics. Clinical Applications|December 8, 2010
The absolute quantification of eight inter-α-trypsin inhibitor heavy chain 4 (ITIH4)-derived peptides in serum from breast cancer patientsIrene van den Broek, Rolf W Sparidans, Annemieke W J van Winden, et al.
Clinical Chemistry and Laboratory Medicine|May 7, 2009
Influence of sample storage duration on serum protein profiles assessed by surface-enhanced laser desorption/ionisation time-of-flight mass spectrometry (SELDI-TOF MS)Marie-Christine W Gast, Carla H van Gils, Lodewijk F A Wessels, et al.
Oncology Reports|June 11, 2009
Serum protein profiling for diagnosis of breast cancer using SELDI-TOF MSMarie-Christine W Gast, Carla H Van Gils, Lodewijk F A Wessels, et al.
Journal of Cancer Research and Clinical Oncology|September 14, 2011
Postoperative serum proteomic profiles may predict recurrence-free survival in high-risk primary breast cancerMarie-Christine W Gast, Marc Zapatka, Harm van Tinteren, et al.
Pageof 6

Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
Trends in Pharmacological Sciences|April 8, 2006
Clinical proteomics: searching for better tumour markers with SELDI-TOF mass spectrometryJudith Y M N Engwegen, Marie-Christine W Gast, Jan H M Schellens, et al.
Biofizika|November 1, 1989
[Phagocytic activity of granulocytes after UV-irradiation]T Walter, M Rytter, W Gast, et al.
BMC Bioinformatics|February 9, 2008
Comparison of normalisation methods for surface-enhanced laser desorption and ionisation (SELDI) time-of-flight (TOF) mass spectrometry dataWouter Meuleman, Judith Ymn Engwegen, Marie-Christine W Gast, et al.
BMC Bioinformatics|February 12, 2009
Analysis of mass spectrometry data using sub-spectraWouter Meuleman, Judith Y M N Engwegen, Marie-Christine W Gast, et al.
Cancer Biomarkers : Section a of Disease Markers|February 1, 2007
SELDI-TOF MS serum protein profiles in breast cancer: assessment of robustness and validityM C W Gast, J M G Bonfrer, E J van Dulken, et al.
BMC Medical Genomics|January 21, 2009
Validation of previously identified serum biomarkers for breast cancer with SELDI-TOF MS: a case control studyAnnemieke W J van Winden, Marie-Christine W Gast, Jos H Beijnen, et al.
Proteomics. Clinical Applications|December 8, 2010
The absolute quantification of eight inter-α-trypsin inhibitor heavy chain 4 (ITIH4)-derived peptides in serum from breast cancer patientsIrene van den Broek, Rolf W Sparidans, Annemieke W J van Winden, et al.
Clinical Chemistry and Laboratory Medicine|May 7, 2009
Influence of sample storage duration on serum protein profiles assessed by surface-enhanced laser desorption/ionisation time-of-flight mass spectrometry (SELDI-TOF MS)Marie-Christine W Gast, Carla H van Gils, Lodewijk F A Wessels, et al.
Oncology Reports|June 11, 2009
Serum protein profiling for diagnosis of breast cancer using SELDI-TOF MSMarie-Christine W Gast, Carla H Van Gils, Lodewijk F A Wessels, et al.
Journal of Cancer Research and Clinical Oncology|September 14, 2011
Postoperative serum proteomic profiles may predict recurrence-free survival in high-risk primary breast cancerMarie-Christine W Gast, Marc Zapatka, Harm van Tinteren, et al.
Pageof 6